Christopher S. Boerner, Ph.D
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- 2023-11-01
- Valid until
- still holds
- Published
- 2026-03-25
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · its source page states the value and the date
- Confidence
- 0.95
Sources
“Christopher S. Boerner, Ph.D. Board Chair & Chief Executive Officer of the Company Director Since: 2023 Age: 55 Board Committees • None Other Public Company Boards • Colgate-Palmolive Company Experience • Bristol Myers Squibb, Chief Executive Officer (November 2023-present)”— what the page says, read 2026-11-08
Cite this claim
Plain text
AsOf. "Bristol-Myers Squibb ceo: Christopher S. Boerner, Ph.D", as of 2023-11-01. Claim clm_FF61856A3386, https://asof.is/claim/clm_FF61856A3386, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm.
APA
AsOf. (2023). Bristol-Myers Squibb ceo: Christopher S. Boerner, Ph.D (as of 2023-11-01) [Record clm_FF61856A3386]. Retrieved November 9, 2026, from https://asof.is/claim/clm_FF61856A3386 (source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm)
BibTeX
@misc{asof_clm_FF61856A3386,
author = {AsOf},
title = {Bristol-Myers Squibb ceo: Christopher S. Boerner, Ph.D},
year = {2023},
howpublished = {\url{https://asof.is/claim/clm_FF61856A3386}},
note = {Claim clm\_FF61856A3386, as of 2023-11-01; source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm},
urldate = {2026-11-09}
}On the record
/claim/clm_FF61856A3386.md/v1/claims/clm_FF61856A3386submit a correction